[go: up one dir, main page]

WO2005052160A1 - A L-sorbosone dehydrogenase as well as the encoding gene and the use thereof - Google Patents

A L-sorbosone dehydrogenase as well as the encoding gene and the use thereof Download PDF

Info

Publication number
WO2005052160A1
WO2005052160A1 PCT/CN2004/001356 CN2004001356W WO2005052160A1 WO 2005052160 A1 WO2005052160 A1 WO 2005052160A1 CN 2004001356 W CN2004001356 W CN 2004001356W WO 2005052160 A1 WO2005052160 A1 WO 2005052160A1
Authority
WO
WIPO (PCT)
Prior art keywords
seq
sorbone
dehydrogenase
sequence
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CN2004/001356
Other languages
French (fr)
Chinese (zh)
Inventor
Qian Jia
Qi Jin
Hongtao Wu
Fan Yang
Junwei Sun
Xiaobing Zhang
Aiyu Hao
Wenfei Geng
Ping Xu
Jianxin Xiu
Ying Zhao
Ping Xie
Zaoji Mi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NORTH CHINA PHARMACEUTICAL GROUP Corp
National Institute for Communicable Disease Control and Prevention of Chinese Center For Disease Control and Prevention
Original Assignee
NORTH CHINA PHARMACEUTICAL GROUP Corp
National Institute for Communicable Disease Control and Prevention of Chinese Center For Disease Control and Prevention
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NORTH CHINA PHARMACEUTICAL GROUP Corp, National Institute for Communicable Disease Control and Prevention of Chinese Center For Disease Control and Prevention filed Critical NORTH CHINA PHARMACEUTICAL GROUP Corp
Publication of WO2005052160A1 publication Critical patent/WO2005052160A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0006Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)

Definitions

  • the invention relates to an L-sorbone dehydrogenase in the field of genetic engineering, a coding gene thereof, an expression method and application thereof. Background technique
  • 2-keto-L-gulonic acid (2-KGA) is an important intermediate for the synthesis of ascorbic acid (vitamin C).
  • vitamin C ascorbic acid
  • NRRL B-21627 US Patent No. 5834231
  • DSM4025 European patent EP9611500. 8
  • L-sorbone oxidase found in IF03293 requires neither a coenzyme nor an electron acceptor.
  • Makover et al. (Biotechnol. Bioeng, 17. 1485. 1975) also reported L-sorbone dehydrogenase (SNDH) activity It is present in Pseudomonas putida ATCC21812 and Gluconobacter suboxydans IF03293 and indicates that NAD or NADP is not its coenzyme.
  • the molecular weight of SNDH discovered by Fujiwara et al. U.S. Patent No. 4,902,617) is 190,000 ⁇ 20,000 Daltons.
  • 2-KGA is produced from sorbitol by 2-step fermentation with microorganisms, and then vitamin C is produced by methyl esterification.
  • three kinds of microorganisms were used, that is, two kinds of microorganisms were involved in the conversion process from L-sorbose to 2-KGA, and one of them was an acid-producing bacterium that transformed L-sorbose to 2-KGA.
  • Gluconobacter oxydans which has production value is usually slower to grow alone and has a lower conversion rate of 2-KGA.
  • the object of the present invention is to provide an L-sorbone dehydrogenase and a gene encoding the same.
  • the L-sorbone dehydrogenase provided by the present invention is a protein having the sequence of SEQ ID NTs: 2 amino acid residues in the Sequence Listing or has a sequence of amino acid residues of at least 80 with SEQ ID Na: 2 in the Sequence Listing.
  • the SEQ ID No : 2 is derived from ketocoronic acid bacteria (eio ⁇ / Jo ⁇ e'M ⁇ A) WB0104 (CCTTCC No. M203094) and consists of 429 amino acid residues.
  • the ketocoronic acid tKetogulonigeniwn sp.) WB0104 was deposited at the China Type Culture Collection (CCTCC) on November 24, 2003 under CCTCC No.M203094.
  • the protein derived from SEQ ID Na: 2 having at least 80% homology with the amino acid residue sequence of SEQ ID Na: 2 in the Sequence Listing and having the same activity as SEQ ID No : 2 is preferably identical to SEQ ID Ns : 2
  • the L-sorbone dehydrogenase may be a protein obtained by expressing a sequence having at least 80% homology with SEQ ID No : 1 in the sequence listing in a host bacterium Escherichia coli or Pichia pastoris.
  • a gene encoding L-sorbone dehydrogenase,% rSNDH is one of the following nucleotide sequences:
  • the SEQ ID Na: 1 sp.) WB0104 CCTCC No. M203094 consisting of 1290 bases.
  • the open reading frame (0RF) of the gene is from base 1 to base 1290 at the 5 'end.
  • Both the expression vector and the cell line containing the gene of the present invention belong to the protection scope of the present invention, and different expression vectors and cell lines (engineering bacteria) can be obtained by using existing molecular biology methods: for example, E. coli BL21 ( DE3), E. coli TOP10, or Pichia X-33.
  • the above-mentioned engineered bacteria containing the gene of the present invention can also be fixed in different vectors by conventional methods to prepare immobilized cells.
  • the L-sorbone dehydrogenase of the present invention can be immobilized on supports such as agarose, acrylamide, and sodium alginate, Preparation of immobilized enzyme.
  • a second object of the present invention is to provide a method for expressing L-sorbone dehydrogenase.
  • the method for expressing L-sorbone dehydrogenase provided by the present invention is a gene encoding an L-sorbone dehydrogenase obtained by amplifying genomic DNA of ketocoronic acid bacteria iKetogulonigenium sp. WB0104 CCTCC No. M20309 as a template
  • the expression host bacteria were introduced to obtain positive clones, and the positive clones were cultured to express L-sorbone dehydrogenase.
  • Ketogulonigenium sp.) WB0104 CCTCC No. M203094 genomic DNA can be extracted by conventional methods.
  • a pair of primers for amplifying the L-sorbone dehydrogenase gene using ketogulonigeniim sp. WB0104 CCTCC No. M203094 as a template can be SEQ ID Na : 3 and SEQ ID Na : 4, SEQ ID Na in the sequence listing Na : 5 and SEQ ID Na : 6 or SEQ ID No : 7 and SEQ ID N 2: 8.
  • SEQ ID No : 3 is composed of 26 bases
  • SEQ ID Na : 4 is composed of 24 bases
  • SEQ ID No : 5 is composed of 32 bases
  • SEQ ID Ns: 6 is composed of 24 bases
  • SEQ ID Na : 7 consists of 35 bases
  • SEQ ID Na : 8 consists of 24 bases.
  • the positive clone may be E. coli DH5 ⁇ , E.coli BL21 (DE3), E.coli TOP10, or Pichia X-33 containing an L-sorbone dehydrogenase-encoding gene.
  • the L-sorbone dehydrogenase of the present invention does not depend on the coenzyme NAD, but the presence of coenzyme NAD can improve the conversion efficiency of the enzyme, the enzyme converts L-sorbone to 2-KGA in a range of 5. 0, the most suitable is 7.5.
  • the whole genome sequence of NO. M203094 was determined by gene annotation, and the key enzyme gene related to the synthesis of 2-keto-L-gulonic acid-the L-sorbone dehydrogenase gene was predicted. Its DNA sequence has very low homology compared with all known L-sorbone dehydrogenase gene sequences.
  • ⁇ Rhodobacter sphaeroides is 68% homologous, 53% homologous to P. syringae SNDH, 50% homologous to alfalfa rhizobium SNDH, and oxidized glucose with another vitamin C-producing bacterium
  • the SNDH in Acidobacteria is essentially non-homologous.
  • the protein (enzyme) produced by expressing this gene in different vectors and hosts by molecular biology methods can effectively convert L-sorbone to 2-keto-L-gulonic acid (2-KGA) in vitro No matter what form of SNDH (including body, secreted protein, fusion protein) has SNDH enzyme activity in vitro, at the same time, when the E.
  • coli engineered bacteria carrying the rSNDH coding gene of the present invention is co-cultured with 2-KGA transforming bacteria
  • the rSNDH of the present invention significantly improves the conversion rate of 2-KGA, and the rSNDH.
  • Encoding gene of the present invention is a key enzyme gene in 2-KGA synthesis.
  • the L-sorbone dehydrogenase gene of the present invention can be used to transform existing 2-KGA-producing bacteria and conduct targeted breeding to increase the yield of 2-KGA.
  • the L-sorbone dehydrogenase gene of the invention or a mutant or fragment thereof is inserted into the genome of an existing 2-KGA-producing bacteria to enhance the activity of the L-sorbone dehydrogenase, or to express the present invention by molecular biological means
  • the L-sorbone dehydrogenase gene is used to synthesize 2-KGA in vitro by using an immobilized enzyme method or an immobilized cell method, or a protein corresponding to the L-sorbone dehydrogenase gene of the present invention is used for the production of 2-KGA, Reduce the production cost of 2-KGA, increase the conversion rate of 2-KGA, reduce the environmental pollution, reduce the demand for energy during the production process, and improve the quality of the product.
  • the invention has important industrial application prospects. BRIEF DESCRIPTION OF THE DRAWINGS
  • Figure 1 shows the electrophoresis map of the PCR amplified product of the L-sorbone dehydrogenase gene.
  • Figure 2 is an SDS-PAGE map of the expression product of the L-sorbone dehydrogenase gene in E. coli BL21 (DE3)
  • Figure 3 is an SDS-PAGE chart of the expression product of L-sorbone dehydrogenase gene in E. coli TOP10.
  • Figure 4 is an SDS-PAGE chart of the expression product of L-sorbone dehydrogenase gene in Pichia pastoris X-33.
  • 5 is the rSNDH activity curve of the positive clone Escherichia coli T0P10 fusion expression
  • Figure 7 shows the relationship between rSNDH enzyme activity and pH
  • Figure 8 is an HPLC spectrum of rSNDH enzyme in the presence of coenzyme for 0 time
  • Figure 9 shows the HPLC profile of rSNDH enzyme in the presence of coenzyme for 5 hours.
  • Figure 10 shows the HPLC spectra of L-sorbone and 2-keto-L-gulonic acid standards.
  • Figure 11 shows the HPLC spectrum of rSNDH enzyme in the absence of coenzyme for 5 hours.
  • Fig. 12 is a mass spectrum of LSNsorbase to 2-KGA in the absence of coenzyme.
  • Fig. 13 is a mass spectrum of a 2-KGA standard.
  • TKetogulonigenium sp. WB0104 (CCTCC No. M203094) in the logarithmic growth phase was collected, and the culture supernatant was detected to contain 2-keto-L-gulonic acid by HPLC.
  • the instrument used in this HPLC method and The reagents are: Two Waters 515 high-performance liquid pumps, Alltech 2000 ELSD; acetonitrile (HPLC grade); trifluoroacetic acid (analytical grade); Milli Q plus pure water.
  • ELSD atomizing gas is N 2 , flow rate 2. 51 / min, drift tube temperature 100 ° C; chromatographic column is Thermo Quest APS2 4. 6mmi. D. X 25cm 5 ⁇ m; mobile phase: acetonitrile-0. 1% ⁇ Aqueous fluoroacetic acid (gradient) with a flow rate of 1.3 ml / min. The injection volume was 20ul. Controls: L-sorbose, 2-keto-L colic acid. Bacterial genomic DNA extraction method ( ⁇ Compiled Guide to the Experiment of Molecular Biology ⁇ Science Press. P.
  • r-sorbone dehydrogenase gene r W sequence is predicted as SEQ ID No : 1, encoding a protein consisting of 429 amino acid residues. (SEQ ID No : 2), and its molecular weight is 45473. 41 Daltons.
  • SEQ ID Na: 1 has very low homology compared to all known L-sorbone dehydrogenase gene sequences. After translation into protein, it has 68% homology with Rhodobacter sphaeroides (SNDH). It has 53% homology with P. syringae SNDH, 50% homology with S. meliloti SNDH, and basically no homology with SNDH in Gluconobacter oxidans, another vitamin C production bacterium.
  • PET11B expression primers
  • PCR was performed using genomic DNA of tKetogulonigenium sp. WB0104 (CCTCC No. M203094) as a template.
  • the 50 ⁇ system contained a final concentration of 1.5 ol / L MgCl 2 and 0.2 ol / L. dNTPs, 0.2 ⁇ mol / L each of 5, primers and 3, primers, 10mraol / L Tris-HCl, 2u TaqDNA polymerase; PCR reaction conditions: 94 ° C for 5 minutes; and then performed 30 for the following conditions Cycle: 1 minute at 94 ° C, 1 minute at 55 ° C, 2 minutes at 72 ° C; 72 ⁇ 10 minutes.
  • the PCR product electrophoresis results are shown in Figure 1.
  • the molecular weight standard (marker) is 250, 500, 750, 1000, 1500, 2000, 2500, 3000, 3500, 4000, 5000, 6000, 8000, 10000, and a, respectively.
  • A is the PCR product of PET11B expression primer electrophoresis. result.
  • the PCR product was recovered and purified by electrophoresis and ligated with pGEM-T-VECTOR using T 4 DNA ligase, and then transformed into DH5 a.
  • the white spots were picked, and the plasmid was extracted with QIAGEN's MINI plasmid extraction column and verified by enzyme digestion to find the correct inserted pGEM- T-VECT0R- rSNDH plasmid, digested with NDEI / BAMHI, digested with agarose electrophoresis After receiving 1.3 kb, it was ligated with the expression vector PET11B, transformed into DH5 ⁇ , plated (containing AMP 100 ⁇ g / ml), picked clones and identified by enzyme digestion to obtain a positive clone plasmid PET11B-rSNDH.
  • the two markers of molecular weight markers are 60,000 and 45,000 respectively; a is the control before induction, and b is the rSNDH expressed by PET11B after induction, and the arrow indicates the target band.
  • the PBAD / T0P0 THIOFUSI0 expression system (Invitrogen) is a fast and efficient cloning and expression system. PCR products can be used directly for cloning without ligase treatment, and can be linked to the vector for expression in 5 minutes, and THI0RED0XIN is used. TRX thioredoxin is used as a fusion peptide to express a foreign protein, so that the foreign protein is expressed in a soluble active form. ⁇ Use PBAD promoter and arabinose as inducer.
  • a PCR reaction was performed using genomic DNA of ketocoronic acid J (etogulonigeniwn sp.) WB0104 (CCTCC No. M203094) as a template.
  • the 50 ⁇ system contained a final concentration of '1.5 ol / L MgCl 2) 0.2 mmol / L dNTPs, 0.2 ⁇ mol / L 5 'bow
  • b is the electrophoresis result of the PCR product of the PBAD / THI0-TOP0 expression primer.
  • the PCR product was directly connected to PBAD / THI0-T0P0 (for cloning process, refer to the INVIT0RGEN PBAD / T0P0-THI0FUSI0N expression kit), and then transformed into TOPIO.
  • the INVITR0GEN Pichia picz ⁇ expression system was used to construct the expression vector piczaA / SND expressing rSNDH in Pichia pastoris.
  • the PCR reaction conditions are as follows:
  • Ketogulonigenium sp. WB0104 (CCTCC No. M203094) genomic DNA was used as a template for the PCR reaction, and then the PCR product was ligated to pGEM-T-VECTOR in accordance with conventional methods. After transformation, the white spot colonies were selected, and the plasmid was extracted and sequenced for identification. The correct pGEM-T-rSNDH and picz a A plasmid DNA identified by sequencing were treated with XHOI, respectively. The kit recovered approximately 1200bp and 3.3kb fragments, and ligated with T 4 DNA ligase. The ligated products were transformed into DH5 a competent bacteria.
  • plasmid Coated on LB plate (containing ZE0CIN 25 ⁇ g / ml). The plasmid was extracted and identified by enzyme digestion. Select the recombinant plasmid picz a A-rSNDH with the correct ligation direction and insertion size, and use the QIAGEN MIDI plasmid extraction kit to extract the plasmid for transformation into Pichia pastoris.
  • a single colony of the transformant was inoculated in 10 ⁇ l of sterile water, 5 ⁇ 1 of lysozyme (51) / ⁇ 1) was added, shaken at 30 ° C for 10 min, and placed in a liquid nitrogen phase for 1 min. After thawing at room temperature, it was directly used as a template.
  • Primer a- Factor Hekou 3, A0X1 (Invitrigen easy select Pichia Expression Kit Manual) was used for PCR detection, and the L-sorbone dehydrogenase gene was detected.
  • Transformant single colonies were inoculated in 50 ml BMGY medium and cultured at 30 ° C to A 6 . .
  • nm «4.0 daily supplementation with methanol, ammonia, and induced expression for 6 days, the samples were centrifuged to collect the supernatant, and analyzed by SDS-PAGE. The results are shown in Figure 4, indicating that a specific band was detected at 45,000 Daltons. An expression product of the L-sorbone dehydrogenase gene was detected.
  • the arrow points to rSNDH, and the molecular weight standards are 94000, 67000, 43000, 30000, and 20100.
  • rSNDH L-sorbitan dehydrogenase
  • the activity of rSNDH expressed by TOP10 fusion is shown in Figure 5, which indicates that the fusion rSNDH has enzymatic activity, and the enzymatic activity is 0.117 u / mg o, which is much higher than the crude enzyme activity reported in the literature (48.5 mu / mg).
  • the unit of enzyme activity is defined as the amount of enzyme required to catalyze the reduction of luMol NAD per minute. Measurements have shown that this enzyme converts L-
  • the pH range for the conversion of sorbone to 2 -KGA is 5.0-9. 0, of which the optimal action 13 ⁇ 4 is 7.5, as shown in FIG. 7.
  • the rSNDH expressed by the fusion of the positive clone E. coli TOP10 was purified by Chelating-SFF chromatography, wherein the chromatography column: 1. 6 X 10cm, affinity ion: Ni 2+ , chromatography conditions: 50 mM PB buffer, pH 7. 0, Imidazole gradient.
  • the purification result is shown in Fig. 6.
  • the arrow indicates the purified rSNDH, the molecular weight is about 57000, and the molecular weight standards are 94000, 67000, 43000, 30000, 20100 in that order.
  • the in vitro conversion test of L-sorbitan by rSNDH was performed according to the conventional method.
  • the reaction system buffer: 50 mM PB, pH 8. 0, L-sorbone: 5 mg / ml, rSNDH enzyme: 0.08 mg / ral, NAD: 0 5mg / ml.
  • the reaction was performed at 37 ° C for 5 hours, and the product 2-KGA was quantitatively determined by HPLC. The results are shown in Figures 8, 9, 10, and 11, indicating that rSNDH converts L-sorbone to 2-KGA in vitro, and the presence of coenzyme NAD is effective. Increase the conversion rate of 2-KGA.
  • the standard concentration of 2-KGA is: 2mg / ml; the standard concentration of L-sorbone is: 2m g / ml; in the absence of coenzyme, the concentration of 2-KGA is: 0.86 m g / ml; In the presence of coenzyme, the production concentration of 2- KGA is: 1. 42 mg / ml. Transformation test in which no part in the reaction NAD verification LS- MS 2 -KGA production (electrospray ionization: ESI, electrospray voltage: 3.
  • 0104 kinds of cultured ketocoronic acid bacteria and E. coli T0P10 with or without PBAD-rSNDH plasmid were mixed (10: 1) for a total of 3ml (containing L-sorbose 2.0%) inoculated into 20ml fermentation medium
  • the final concentration of arabinose is 0.02%.
  • Industrial applicability The present invention is based on Ketogulonigenium sp. WB0104 CCTCC.
  • the genome-wide sequence of NO. M203094 was determined by gene annotation to predict the key enzyme gene related to 2-keto-L-gulonic acid synthesis-the L-sorbone dehydrogenase gene (irSNDH).
  • the protein (enzyme) produced by expressing this gene in different vectors and hosts by molecular biology methods can effectively convert L-sorbone to 2-keto-L-gulonic acid (2-KGA) in vitro SNDH (including bodies, secreted proteins, and fusion proteins) expressed in any form has SNDH enzyme activity in vitro, and at the same time, when the engineered coli bacteria carrying the rSNDH-encoding gene of the present invention is co-cultured with 2-KGA transforming bacteria,
  • the rSNDH of the present invention significantly improves the conversion rate of 2-KGA.
  • the L-sorbone dehydrogenase gene of the present invention can be used to modify existing 2-KGA-producing bacteria and conduct targeted breeding to increase the yield of 2-KGA.
  • the L-sorbone dehydrogenase gene of the present invention or the The mutant or fragment is inserted into the existing 2-KGA-producing bacteria genome to enhance the activity of L-sorbone dehydrogenase, or to express the L-sorbone dehydrogenase gene of the present invention by molecular biology means, and the immobilization Enzyme method or immobilized cell method to synthesize 2-KGA in vitro, or synthesize the protein corresponding to the L-sorbone dehydrogenase gene of the present invention for the production of 2-KGA, reduce the production cost of 2-KGA, and increase the 2-KGA
  • the present invention has important industrial application prospects by reducing the environmental pollution, reducing the demand for energy during the production process, and improving the quality of products.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

The present invention discloses a L-sorbosone dehydrogenase as well as the encoding gene and the use thereof. The L-sorbosone dehydrogenase provided by the invention is the protein with the amino acid residue sequence of SEQ ID NO:2 in sequence listing or the protein derived from SEQ ID NO:2, and sharing at least 80% homology with the amino acid residue sequence of SEQ ID NO:2 in sequence listing and having the same activity with SEQ ID NO:2. The gene encoding for the L-sorbosone dehydrogenase is one of the following nucleotide sequences: 1)SEQ ID NO:1 in sequence listing; 2) the polynucleotide encoding the protein sequence of SEQ ID NO:2 in sequence listing; 3)the DNA sequence sharing aboye 80% homology with the DNA sequence defined by SEQ ID NO:1 in sequence listing and encoding the saine functional protein. When the E. coli engineering strain carried the gene encoding for the L-sorbosone dehydrogenase of the invention is co-cultivated with the bacteria converting 2-KGA, the rSNDH of the invention can significantly improve the efficiency of conversion to 2-KGA .

Description

一种 L-山梨酮脱氢酶及其编码基因与应用 技术领域  L-sorbone dehydrogenase, coding gene and application thereof

本发明涉及基因工程领域中一种 L-山梨酮脱氢酶及其编码基因与表达方法、 应用。 背景技术  The invention relates to an L-sorbone dehydrogenase in the field of genetic engineering, a coding gene thereof, an expression method and application thereof. Background technique

2-酮基 -L-古龙酸 (2-KGA)是合成抗坏血酸(维生素 C) 的重要中间体, 巳 知有多种微生物 将 L-山梨醇 /山梨糖转化为 2- KGA。如 Stoddard等所用的 NRRL B - 21627 (美国专利 US 5834231 ) , T. Hoshino等所提到的 DSM4025 (欧洲专利 EP9611500. 8) , 尹光琳等提到的 SCB329等 (中国专利 96116464. 6) 。  2-keto-L-gulonic acid (2-KGA) is an important intermediate for the synthesis of ascorbic acid (vitamin C). There are many known microorganisms that convert L-sorbitol / sorbose to 2-KGA. For example, NRRL B-21627 (US Patent No. 5834231) used by Stoddard et al., DSM4025 (European patent EP9611500. 8) mentioned by T. Hoshino et al., SCB329 et al. Mentioned by Yin Guanglin et al.

有多篇文献艮道用微生物能够将 L-山梨糖转化为 2- KGA,美国专利 3907. 639 公开了属于醋菌属、 假单孢菌、 沙雷氏杆菌、 葡萄状球菌、 气杆菌、 产碱杆菌、 青霉菌、 假丝酵母以及葡萄糖酸菌的微生物具有上述转化活性。 Kitamura等 (Europe J. Appl . Microbiol. 2. 1. 1975)报道在氧化葡萄糖杆菌生黑亚种  There are many literatures on the use of microorganisms capable of converting L-sorbose to 2-KGA. U.S. Patent 3907.639 discloses belonging to the genus Acetobacter, Pseudomonas, Serratia, Staphylococcus, Aerobacter, Microorganisms of Alkali, Penicillium, Candida, and Gluconobacter have the above-mentioned transformation activity. Kitamura et al. (Europe J. Appl. Microbiol. 2. 1. 1975) reported in Gluconobacter oxydans

IF03293中发现的 L-山梨酮氧化酶的酶活性既不需要辅酶也不需要电子受体, Makover等(Biotechnol. Bioeng, 17. 1485. 1975 )也报道 L-山梨酮脱氢酶(SNDH) 活性存在于假单孢菌 putida ATCC21812及氧化葡萄糖杆菌生黑亚种 IF03293并 指出 NAD或 NADP不是其辅酶。 Fujiwara等(美国专利 4902617 ) 所发现的 SNDH 分子量为 190000 ±20000道尔顿, 由 4个亚基组成, 来源为氧化葡萄糖酸菌, 美 国专利 5085993发现的 SNDH来源于假单孢菌 putida, 其分子量约为 47000道尔 顿, 在基因水平仅有 Yashimasa Saito等 (Biotechnology and Bioengineering, Vol , 58, N0S APRIL 20/May 5 1998 )在氧化葡萄糖酸菌 T- 100中克隆出 SNDH 基因, 该 SNDH甶 498个氨基酸组成。 The enzymatic activity of L-sorbone oxidase found in IF03293 requires neither a coenzyme nor an electron acceptor. Makover et al. (Biotechnol. Bioeng, 17. 1485. 1975) also reported L-sorbone dehydrogenase (SNDH) activity It is present in Pseudomonas putida ATCC21812 and Gluconobacter suboxydans IF03293 and indicates that NAD or NADP is not its coenzyme. The molecular weight of SNDH discovered by Fujiwara et al. (U.S. Patent No. 4,902,617) is 190,000 ± 20,000 Daltons. It consists of 4 subunits and is derived from Gluconobacter oxydans. Approximately 47,000 Daltons. At the gene level, only Yashimasa Saito et al. (Biotechnology and Bioengineering, Vol, 58, NOS APRIL 20 / May 5 1998) cloned the SNDH gene from Gluconobacter oxydans T-100, the SNDH 甶 498 Amino acid composition.

对比化学合成法生产维生素 C的七步化学反应, 用微生物经 2步发酵由山梨 醇生成 2- KGA, 再经甲醇酯化生成维生素 C是目前中国通用的方法。 但在 2步发 酵中使用了 3种微生物,即在由 L-山梨糖到 2-KGA的转化过程中有 2种微生物参 与,其中一个是转化 L-山梨糖为 2 - KGA的产酸菌。有生产应用价值的氧化葡萄糖 酸杆菌通常单独生长较慢, 2-KGA的转化率较低, 所以目前工业生产应用的均是 采用两菌共生, Π枯草杆菌、 苏云金芽孢杆菌、 巨大芽孢杆菌等与产酸菌共同发 酵。而在实际生产中仍存在相当多的问题, 比如转化率低、工艺控制较为复杂等。 发明创造内容 本发明的目的是提供一种 L-山梨酮脱氢酶及其编码基因。 In contrast to the seven-step chemical reaction for the production of vitamin C by chemical synthesis, 2-KGA is produced from sorbitol by 2-step fermentation with microorganisms, and then vitamin C is produced by methyl esterification. But in the two-step fermentation, three kinds of microorganisms were used, that is, two kinds of microorganisms were involved in the conversion process from L-sorbose to 2-KGA, and one of them was an acid-producing bacterium that transformed L-sorbose to 2-KGA. Gluconobacter oxydans which has production value is usually slower to grow alone and has a lower conversion rate of 2-KGA. Therefore, the current industrial production and application are based on the symbiosis of two bacteria, Π subtilis, Bacillus thuringiensis, Bacillus giant Acidogenic bacteria co-ferment. However, there are still many problems in actual production, such as low conversion rate and more complicated process control. SUMMARY OF THE INVENTION The object of the present invention is to provide an L-sorbone dehydrogenase and a gene encoding the same.

本发明所提供的 L-山梨酮脱氢酶,名称为 rSNDH,是具有序列表中 SEQ ID NTs: 2氨基酸残基序列的蛋白质或与序列表中 SEQID Na: 2的氨基酸残基序列具有至 少 80%同源性且具有与 SEQ ID No: 2相同活性的由 SEQ ID Na: 2衍生的蛋白质。 The L-sorbone dehydrogenase provided by the present invention, named rSNDH, is a protein having the sequence of SEQ ID NTs: 2 amino acid residues in the Sequence Listing or has a sequence of amino acid residues of at least 80 with SEQ ID Na: 2 in the Sequence Listing. A protein derived from SEQ ID Na: 2 with% homology and the same activity as SEQ ID No : 2.

所述 SEQ ID No: 2来源于酮古龙酸菌( eio^/Jo^^e 'M^A )WB0104 (CCTTCC No. M203094), 由 429个氨基酸残基组成。 The SEQ ID No : 2 is derived from ketocoronic acid bacteria (eio ^ / Jo ^^ e'M ^ A) WB0104 (CCTTCC No. M203094) and consists of 429 amino acid residues.

酮古龙酸菌 tKetogulonigeniwn sp. ) WB0104, 已于 2003年 11月 24日保 藏于中国典型培养物保藏中心 (简称 CCTCC) , 保藏号为 CCTCC No.M203094。  The ketocoronic acid tKetogulonigeniwn sp.) WB0104 was deposited at the China Type Culture Collection (CCTCC) on November 24, 2003 under CCTCC No.M203094.

所述与序列表中 SEQ ID Na: 2的氨基酸残基序列具有至少 80%同源性且具有 与 SEQ ID No: 2相同活性的由 SEQ ID Na: 2衍生的蛋白质优选为与 SEQ ID Ns: 2具有至少 90%同源性且具有与 SEQ ID a: 2相同活性的由 SEQ ID Na: 2衍生 的蛋白质, 尤其优选为将 SEQ ID No: 2的氨基酸残基序列经过一个或几个氨基 酸残基的取代、 缺失或添加且具有与 SEQ ID Na: 2相同活性的由 SEQ ID Ns: 2 衍生的蛋白质。 The protein derived from SEQ ID Na: 2 having at least 80% homology with the amino acid residue sequence of SEQ ID Na: 2 in the Sequence Listing and having the same activity as SEQ ID No : 2 is preferably identical to SEQ ID Ns : 2 A protein derived from SEQ ID Na : 2 having at least 90% homology and having the same activity as SEQ ID a: 2; it is particularly preferred to pass the amino acid residue sequence of SEQ ID No : 2 through one or several amino acid residues A protein derived from SEQ ID Ns : 2 with the substitution, deletion, or addition of a base and having the same activity as SEQ ID Na: 2.

所述 L -山梨酮脱氢酶可为将与序列表中 SEQ ID No: 1具有至少 80%同源'性 的序列在宿主菌大肠杆菌或毕赤酵母中表达得到的蛋白质。 The L-sorbone dehydrogenase may be a protein obtained by expressing a sequence having at least 80% homology with SEQ ID No : 1 in the sequence listing in a host bacterium Escherichia coli or Pichia pastoris.

一种 L-山梨酮脱氢酶的编码基因, % rSNDH, 是下列核苷酸序列之一: A gene encoding L-sorbone dehydrogenase,% rSNDH, is one of the following nucleotide sequences:

1)序列表中的 SEQ ID Na: 1; 1) SEQ ID Na: 1 in the sequence listing;

2) 编码序列表中 SEQ ID No: 2蛋白质序列的多核苷酸; 2) a polynucleotide encoding the protein sequence of SEQ ID No : 2 in the sequence listing;

3)与序列表中 SEQID No: 1限定的 DNA序列具有 80%以上同源性, 且编码 相同功能蛋白质的 DNA序列, 其中, 优选为与序列表中 SEQID Na: 1限定的 DNA 序列具有 90%以上同源性, 且编码相同功能蛋白质的 DNA序列。  3) It has a homology of more than 80% with the DNA sequence defined by SEQID No: 1 in the Sequence Listing, and encodes the same functional protein. Among them, it is preferably 90% of the DNA sequence defined by SEQID Na: 1 in the Sequence Listing. The above homology, and the DNA sequence encoding the same functional protein.

所述 SEQ ID Na: 1

Figure imgf000004_0001
sp. )WB0104 CCTCC No. M203094, 由 1290个碱基组成, 该基因的开放阅读框架 (0RF)为自 5' 端第 1 到第 1290位碱基。 The SEQ ID Na: 1
Figure imgf000004_0001
sp.) WB0104 CCTCC No. M203094, consisting of 1290 bases. The open reading frame (0RF) of the gene is from base 1 to base 1290 at the 5 'end.

含有本发明基因的表达载体和细胞系均属于本发明的保护范围, 利用现有分 子生物学的方法可以得到不同的表达载体和细胞系 (工程菌) : 如, 含有本发明 基因大肠杆菌 BL21 (DE3) 、 大肠杆菌 TOP10或毕赤酵母 X- 33。 也可用常规方法 将含有本发明基因的上述工程菌固定于不同的载体中, 制备固定化细胞。  Both the expression vector and the cell line containing the gene of the present invention belong to the protection scope of the present invention, and different expression vectors and cell lines (engineering bacteria) can be obtained by using existing molecular biology methods: for example, E. coli BL21 ( DE3), E. coli TOP10, or Pichia X-33. The above-mentioned engineered bacteria containing the gene of the present invention can also be fixed in different vectors by conventional methods to prepare immobilized cells.

可将本发明的 L-山梨酮脱氢酶固定在琼脂糖、丙烯酰胺、藻酸钠等支持物上, 制备固定化酶。 The L-sorbone dehydrogenase of the present invention can be immobilized on supports such as agarose, acrylamide, and sodium alginate, Preparation of immobilized enzyme.

本发明的第二个目的是提供一种表达 L-山梨酮脱氢酶的方法。  A second object of the present invention is to provide a method for expressing L-sorbone dehydrogenase.

本发明所提供的表达 L-山梨酮脱氢酶的方法, 是将以酮古龙酸菌 iKetogulonigenium sp. ) WB0104 CCTCC No. M20309 基因组 DNA为模板扩增得 到的 L-山梨酮脱氢酶的编码基因导入表达宿主菌,得到阳性克隆,培养阳性克隆, 表达 L-山梨酮脱氢酶。  The method for expressing L-sorbone dehydrogenase provided by the present invention is a gene encoding an L-sorbone dehydrogenase obtained by amplifying genomic DNA of ketocoronic acid bacteria iKetogulonigenium sp. WB0104 CCTCC No. M20309 as a template The expression host bacteria were introduced to obtain positive clones, and the positive clones were cultured to express L-sorbone dehydrogenase.

其中, 酮古龙酸菌 Ketogulonigenium sp. ) WB0104 CCTCC No. M203094基 因组 DNA可按常规方法提取。 以酮古龙酸菌 Ketogulonigeniim sp. WB0104 CCTCC No. M203094基因组 DNA为模板扩增 L-山梨酮脱氢酶基因的一对引物可为 序列表中 SEQ ID Na : 3和 SEQ ID Na : 4、 SEQ ID Na: 5和 SEQ ID Na : 6或 SEQ ID No: 7和 SEQ ID N2 : 8。 Among them, Ketogulonigenium sp.) WB0104 CCTCC No. M203094 genomic DNA can be extracted by conventional methods. A pair of primers for amplifying the L-sorbone dehydrogenase gene using ketogulonigeniim sp. WB0104 CCTCC No. M203094 as a template can be SEQ ID Na : 3 and SEQ ID Na : 4, SEQ ID Na in the sequence listing Na : 5 and SEQ ID Na : 6 or SEQ ID No : 7 and SEQ ID N 2: 8.

其中, SEQ ID No : 3由 26个碱基组成, SEQ ID Na : 4由 24个碱基组成, SEQ ID No : 5由 32个碱基组成, SEQ ID Ns : 6由 24个碱基组成, SEQ ID Na : 7由 35个碱基组成, SEQ ID Na : 8由 24个碱基组成。 Among them, SEQ ID No : 3 is composed of 26 bases, SEQ ID Na : 4 is composed of 24 bases, SEQ ID No : 5 is composed of 32 bases, and SEQ ID Ns: 6 is composed of 24 bases, SEQ ID Na : 7 consists of 35 bases, and SEQ ID Na : 8 consists of 24 bases.

所述阳性克隆可为含有 L-山梨酮脱氢酶编码基因的大肠杆菌 DH5 α、 大肠杆 菌 BL21 (DE3 ) 、 大肠杆菌 T0P10或毕赤酵母 X- 33。  The positive clone may be E. coli DH5α, E.coli BL21 (DE3), E.coli TOP10, or Pichia X-33 containing an L-sorbone dehydrogenase-encoding gene.

本发明的 L-山梨酮脱氢酶不依赖辅酶 NAD, 但辅酶 NAD的存在能够提高该酶 的转化效率, 该酶将 L-山梨酮转化为 2- KGA的 ίΉ范围为 5. 0-9. 0, 最适为 7. 5。  0-9. The L-sorbone dehydrogenase of the present invention does not depend on the coenzyme NAD, but the presence of coenzyme NAD can improve the conversion efficiency of the enzyme, the enzyme converts L-sorbone to 2-KGA in a range of 5. 0, the most suitable is 7.5.

本发明通过对酮古龙酸菌 Ketogulonigeniwn sp. ) WB0104 CCTCC In the present invention, Keto g ulonigeniwn sp.) WB0104 CCTCC

NO. M203094的全基因组序列测定, 经基因注释, 预测出与 2-酮基- L-古龙酸合成 有关的关键酶基因一 L-山梨酮脱氢酶基因 。 其 DNA序列与所有已知的 L-山梨酮脱氢酶基因序列相比同源性很低, 翻译成蛋白后与紅色非硫黄 菌The whole genome sequence of NO. M203094 was determined by gene annotation, and the key enzyme gene related to the synthesis of 2-keto-L-gulonic acid-the L-sorbone dehydrogenase gene was predicted. Its DNA sequence has very low homology compared with all known L-sorbone dehydrogenase gene sequences.

{Rhodobacter sphaeroides) 有 68%的同源性, 与丁香假单胞菌 SNDH有 53%同 源性, 与苜蓿根瘤菌 SNDH有 50%同源性,而与另一种维生素 C生产用菌氧化葡萄 糖酸杆菌中的 SNDH基本无同源性。 用分子生物学手段将该基因表达于不同的载 体及宿主中所产生的蛋白 (酶)均能在体外有效地将 L-山梨酮转化为 2-酮基 -L - 古龙酸 (2-KGA) , 不论任何形式表达的 SNDH (包含体, 分泌蛋白, 融合蛋白) 均在体外具有 SNDH酶活性, 同时, 携有本发明的 rSNDH编码基因的 E. coli工程 菌与 2- KGA转化菌共培养时, 本发明的 rSNDH显著提高 2-KGA的转化率, 本发明 的 rSNDH.编码基因为 2- KGA合成中的关键酶基因。可利用本发明的 L-山梨酮脱氢 酶基因对现有的 2- KGA产生菌进行改造、 定向育种, 提高 2- KGA的产量, 如将本 发明的 L-山梨酮脱氢酶基因或其突变体或片段插入现有的 2- KGA产生菌基因组 中, 以增强 L-山梨酮脱氢酶的活性, 或用分子生物学手段表达本发明的 L-山梨 酮脱氢酶基因, 利用固定化酶法或固定化细胞法在体外合成 2-KGA, 或合成本发 明的 L-山梨酮脱氢酶基因对应的蛋白质用于 2- KGA的生产,降低 2- KGA的生产成 本、 提高 2-KGA的转化率、 减少对环境的污染、 减少生产过程对能源的需求、 提 高产品的质量。 本发明具有重要的工业应用前景。 附图说明 {Rhodobacter sphaeroides) is 68% homologous, 53% homologous to P. syringae SNDH, 50% homologous to alfalfa rhizobium SNDH, and oxidized glucose with another vitamin C-producing bacterium The SNDH in Acidobacteria is essentially non-homologous. The protein (enzyme) produced by expressing this gene in different vectors and hosts by molecular biology methods can effectively convert L-sorbone to 2-keto-L-gulonic acid (2-KGA) in vitro No matter what form of SNDH (including body, secreted protein, fusion protein) has SNDH enzyme activity in vitro, at the same time, when the E. coli engineered bacteria carrying the rSNDH coding gene of the present invention is co-cultured with 2-KGA transforming bacteria The rSNDH of the present invention significantly improves the conversion rate of 2-KGA, and the rSNDH. Encoding gene of the present invention is a key enzyme gene in 2-KGA synthesis. The L-sorbone dehydrogenase gene of the present invention can be used to transform existing 2-KGA-producing bacteria and conduct targeted breeding to increase the yield of 2-KGA. The L-sorbone dehydrogenase gene of the invention or a mutant or fragment thereof is inserted into the genome of an existing 2-KGA-producing bacteria to enhance the activity of the L-sorbone dehydrogenase, or to express the present invention by molecular biological means The L-sorbone dehydrogenase gene is used to synthesize 2-KGA in vitro by using an immobilized enzyme method or an immobilized cell method, or a protein corresponding to the L-sorbone dehydrogenase gene of the present invention is used for the production of 2-KGA, Reduce the production cost of 2-KGA, increase the conversion rate of 2-KGA, reduce the environmental pollution, reduce the demand for energy during the production process, and improve the quality of the product. The invention has important industrial application prospects. BRIEF DESCRIPTION OF THE DRAWINGS

图 1为 L-山梨酮脱氢酶基因的 PCR扩增产物的电泳图谱  Figure 1 shows the electrophoresis map of the PCR amplified product of the L-sorbone dehydrogenase gene.

图 2为 L-山梨酮脱氢酶基因在大肠杆菌 BL21 (DE3 )中表达产物的 SDS- PAGE 图谱  Figure 2 is an SDS-PAGE map of the expression product of the L-sorbone dehydrogenase gene in E. coli BL21 (DE3)

图 3为 L-山梨酮脱氢酶基因在大肠杆菌 T0P10中表达产物的 SDS-PAGE图谱 图 4为 L-山梨酮脱氢酶基因在毕赤酵母 X- 33中表达产物的 SDS- PAGE图谱 图 5为阳性克隆大肠杆菌 T0P10融合表达的 rSNDH的活性曲线  Figure 3 is an SDS-PAGE chart of the expression product of L-sorbone dehydrogenase gene in E. coli TOP10. Figure 4 is an SDS-PAGE chart of the expression product of L-sorbone dehydrogenase gene in Pichia pastoris X-33. 5 is the rSNDH activity curve of the positive clone Escherichia coli T0P10 fusion expression

图 6为阳性克隆大肠杆菌 TOP10融合表达的 rSNDH的 Chelating- SFF层析纯 化结果  Figure 6 Chelating-SFF chromatographic purification results of rSNDH expressed by the positive clone E. coli TOP10 fusion

图 7为 rSNDH的酶活性与 pH的关系曲线  Figure 7 shows the relationship between rSNDH enzyme activity and pH

图 8为 rSNDH酶在辅酶存在条件下反应 0时间的 HPLC图谱  Figure 8 is an HPLC spectrum of rSNDH enzyme in the presence of coenzyme for 0 time

图 9为 rSNDH酶在辅酶存在条件下反应 5小时的 HPLC图谱  Figure 9 shows the HPLC profile of rSNDH enzyme in the presence of coenzyme for 5 hours.

图 10为 L-山梨酮和 2-酮基- L-古龙酸标准品的 HPLC图谱  Figure 10 shows the HPLC spectra of L-sorbone and 2-keto-L-gulonic acid standards.

图 11为 rSNDH酶在没有辅酶存在条件下反应 5小时的 HPLC图谱  Figure 11 shows the HPLC spectrum of rSNDH enzyme in the absence of coenzyme for 5 hours.

图 12为 rSNDH酶在没有辅酶存在条件下将 L-山梨酮转化为 2 - KGA的质谱图 图 13为 2 -KGA标准品的质谱图 具体实施方式  Fig. 12 is a mass spectrum of LSNsorbase to 2-KGA in the absence of coenzyme. Fig. 13 is a mass spectrum of a 2-KGA standard.

实施例 1、 L-山梨酮脱氢酶基因 r0MW的获得  Example 1.Obtainment of L-sorbone dehydrogenase gene r0MW

华北制药集团有限责任公司维生素 C生产用菌株酮古龙酸菌  North China Pharmaceutical Group Co., Ltd. ketocoronic acid strain for vitamin C production

{Ketogulonigeniwn sp. ) WB0104 CCTCC No. M203094, 用于发酵法将 L-山梨糖 转化为 2-酮基- L-古龙酸, 后者是维生素 C的重要前体。 收集对数生长期的酮古 龙酸菌 tKetogulonigenium sp. ) WB0104 (CCTCC No. M203094) , 用 HPLC方法检 测其培养上清中含有 2-酮基- L-古龙酸, 该 HPLC方法中所用的仪器及试剂有: Waters 515 高效液相泵两台, Alltech 2000型 ELSD; 乙腈 (HPLC级) ; 三氟 乙酸 (分析纯) ; Milli Q plus 纯水。 ELSD雾化气为 N2, 流速 2. 51/min, 漂移 管温度 100 °C; 色谱柱为 Thermo Quest APS2 4. 6mmi. d. X 25cm 5 μ m; 流动相: 乙腈 -0. 1%三氟乙酸水溶液 (梯度) , 流速 1. 3 ml/min。 进样量 20ul。 对照品: L-山梨糖, 2-酮基- L古龙酸。 以细菌基因组 DNA提取方法( 《精编分子生物学实 验指南》 科学出版社. 39页) 提取基因组 DNA, 按全基因组鸟枪法进行基因组序 列测定(Fleischmann RD, Adams MD, et al. Science. 1995. 269 (5223) : 496-512 ) , 共进行 35000个反应; 测序总长度达 18M,为其染色体 DNA近 6倍的覆盖率。然后 用 PHRED- PHRAP, GLIMMER软件包拼接注释和进行 0RF预测根据基因注释结果, 预测 L-山梨酮脱氢酶基因 r W 序列为 SEQ ID No : 1, 编码一个由 429个氨基 酸残基组成的蛋白质(SEQ ID No : 2 ),其分子量为 45473. 41 道尔顿。 SEQ ID Na : 1的 DNA序列与所有已知的 L-山梨酮脱氢酶基因序列相比同源性很低, 翻译成蛋 白后与紅色非硫黄細菌 Rhodobacter sphaeroides) SNDH有 68%的同源性, 与 丁香假单胞菌 SNDH有 53%同源性, 与苜蓿根瘤菌 SNDH有 50%同源性, 而与另一 种维生素 C生产用菌氧化葡萄糖酸杆菌中的 SNDH基本无同源性。 {Ketogulonigeniwn sp.) WB0104 CCTCC No. M203094, which is used in fermentation to convert L-sorbose to 2-keto-L-gulonic acid, which is an important precursor of vitamin C. TKetogulonigenium sp. WB0104 (CCTCC No. M203094) in the logarithmic growth phase was collected, and the culture supernatant was detected to contain 2-keto-L-gulonic acid by HPLC. The instrument used in this HPLC method and The reagents are: Two Waters 515 high-performance liquid pumps, Alltech 2000 ELSD; acetonitrile (HPLC grade); trifluoroacetic acid (analytical grade); Milli Q plus pure water. ELSD atomizing gas is N 2 , flow rate 2. 51 / min, drift tube temperature 100 ° C; chromatographic column is Thermo Quest APS2 4. 6mmi. D. X 25cm 5 μ m; mobile phase: acetonitrile-0. 1% 三Aqueous fluoroacetic acid (gradient) with a flow rate of 1.3 ml / min. The injection volume was 20ul. Controls: L-sorbose, 2-keto-L colic acid. Bacterial genomic DNA extraction method (《Compiled Guide to the Experiment of Molecular Biology》 Science Press. P. 39) was used to extract genomic DNA and determine the genome sequence according to the whole genome shotgun method (Fleischmann RD, Adams MD, et al. Science. 1995. 269 (5223): 496-512), and carried out a total of 35,000 reactions; the total length of the sequencing reached 18M, covering nearly 6 times of its chromosomal DNA. Then use PHRED-PHRAP, GLIMMER software to assemble annotations and perform 0RF prediction. According to the gene annotation results, the r-sorbone dehydrogenase gene r W sequence is predicted as SEQ ID No : 1, encoding a protein consisting of 429 amino acid residues. (SEQ ID No : 2), and its molecular weight is 45473. 41 Daltons. The DNA sequence of SEQ ID Na: 1 has very low homology compared to all known L-sorbone dehydrogenase gene sequences. After translation into protein, it has 68% homology with Rhodobacter sphaeroides (SNDH). It has 53% homology with P. syringae SNDH, 50% homology with S. meliloti SNDH, and basically no homology with SNDH in Gluconobacter oxidans, another vitamin C production bacterium.

实施例 2、 L -山梨酮脱氢酶基因 rfW 的表达  Example 2.Expression of L-sorbone dehydrogenase gene rfW

1、 PET-11B (Strategene )表达 rSNDH  1.PET-11B (Strategene) express rSNDH

PET11B表达引物:  PET11B expression primers:

5' 引物: GACATATGAGCGTTCTGGCCAAATTC (SEQ ID Ns : 3 )  5 'Primer: GACATATGAGCGTTCTGGCCAAATTC (SEQ ID Ns: 3)

3, 引物: CAGGATCCTTACGCAGCGGAAATC (SEQ ID Na : 4) 3. Primer: CAGGATCCTTACGCAGCGGAAATC (SEQ ID Na : 4)

以酮古龙酸菌 tKetogulonigenium sp. ) WB0104 (CCTCC No. M203094)基因 组 DNA 为模板进行 PCR 反应, 50 μ ΐ 体系中含有终浓度为 1. 5匪 ol/L MgCl2, 0. 2画 ol/L dNTPs , 各 0. 2 μ mol/L 的 5, 引物和 3, 引物, 10mraol/L Tris- HCl, 2u TaqDNA聚合酶; PCR反应条件为: 94°C 5分钟; 然后在如下条件下 进行 30个循环: 94°C 1分钟, 55°C 1分钟, 72°C2分钟; 72Ό 10分钟。 PCR产物 电泳结果如图 1所示,表明 PCR产物大小为 1. 3Kb。 图中,分子量标准(marker ) 从小到大依次为 250, 500, 750, 1000, 1500, 2000, 2500, 3000, 3500, 4000, 5000, 6000, 8000, 10000, a为 PET11B表达引物的 PCR产物电泳结果。 PCR was performed using genomic DNA of tKetogulonigenium sp. WB0104 (CCTCC No. M203094) as a template. The 50 μΐ system contained a final concentration of 1.5 ol / L MgCl 2 and 0.2 ol / L. dNTPs, 0.2 μmol / L each of 5, primers and 3, primers, 10mraol / L Tris-HCl, 2u TaqDNA polymerase; PCR reaction conditions: 94 ° C for 5 minutes; and then performed 30 for the following conditions Cycle: 1 minute at 94 ° C, 1 minute at 55 ° C, 2 minutes at 72 ° C; 72Ό 10 minutes. 3Kb。 The PCR product electrophoresis results are shown in Figure 1. In the figure, the molecular weight standard (marker) is 250, 500, 750, 1000, 1500, 2000, 2500, 3000, 3500, 4000, 5000, 6000, 8000, 10000, and a, respectively. A is the PCR product of PET11B expression primer electrophoresis. result.

PCR产物经电泳回收纯化与 pGEM-T- VECTOR用 T4 DNA连接酶连接, 然后转化 DH5 a , 挑取白斑, 用 QIAGEN的 MINI质粒提取柱提取质粒并用酶切验证, 找出 正确插入的 pGEM- T-VECT0R- rSNDH质粒后, 经 NDEI/BAMHI,酶切并琼脂糖电泳回 收 1. 3kb后,与表达载体 PET11B连接,转化 DH5 α,铺平板(含 AMP100 μ g/ml ) , 挑取克隆并用酶切鉴定, 得阳性克隆质粒 PET11B- rSNDH。 The PCR product was recovered and purified by electrophoresis and ligated with pGEM-T-VECTOR using T 4 DNA ligase, and then transformed into DH5 a. The white spots were picked, and the plasmid was extracted with QIAGEN's MINI plasmid extraction column and verified by enzyme digestion to find the correct inserted pGEM- T-VECT0R- rSNDH plasmid, digested with NDEI / BAMHI, digested with agarose electrophoresis After receiving 1.3 kb, it was ligated with the expression vector PET11B, transformed into DH5α, plated (containing AMP 100 μg / ml), picked clones and identified by enzyme digestion to obtain a positive clone plasmid PET11B-rSNDH.

提取阳性克隆(含质粒 PET11B- rSNDH)中的质粒, 转化表达用宿主大肠杆菌 BL21 (DE3) 挑单菌落接种到 5mlLB培养基中 (含 AMP100 μ g/ml ) 37°C培养过 夜, 按 1%接种量接种到 50mlLB培养基中 (含 AMP100 μ g/ml )培养至 0D=0. 6-1, 加 IPTG诱导 (终浓度 1. 0ramol/L) ,继续培养 4个小时, 离心收集菌体, 进行 SDS-PAGE检测, 结果如图 2所示, 表明在 45000道尔顿处检测到特异条带, 说 明检测到 L-山梨酮脱氢酶基因的表达产物。 图中, 分子量标准(marker)两条带 大小分别为 60000, 45000; a为诱导前对照, b为诱导后 PET11B表达的 rSNDH, 箭头所指为目的条带。  Extract the plasmids from the positive clones (containing the plasmid PET11B-rSNDH) and transform them for expression with the host E. coli BL21 (DE3). Single colonies were inoculated into 5ml LB medium (containing AMP100 μg / ml) and cultured overnight at 37 ° C. Press 1% The inoculation amount was inoculated into 50ml LB medium (containing AMP100 μg / ml) and cultured to 0D = 0. 6-1, induced by IPTG (final concentration 1.0ramol / L), and continued to culture for 4 hours, and the cells were collected by centrifugation, The results of SDS-PAGE were shown in Fig. 2, which showed that a specific band was detected at 45,000 Daltons, indicating that the expression product of the L-sorbone dehydrogenase gene was detected. In the figure, the two markers of molecular weight markers are 60,000 and 45,000 respectively; a is the control before induction, and b is the rSNDH expressed by PET11B after induction, and the arrow indicates the target band.

2、 PBAD/THI0-T0P0表达 SNDH  2.PBAD / THI0-T0P0 expresses SNDH

PBAD/T0P0 THIOFUSI0 表达系统 (Invitrogen ) 是一种快速高效的克隆表 达系统, 可以将 PCR产物直接用于克隆, 不用连接酶处理, 5分钟就可完成连接 到载体用于表达, 而且釆用了 THI0RED0XIN TRX硫氧还蛋白作为融合肽来表达外 源蛋白, 使外源蛋白以可溶的活性形式表达。 釆用 PBAD 的启动子, 用阿拉伯糖 作为诱导物。  The PBAD / T0P0 THIOFUSI0 expression system (Invitrogen) is a fast and efficient cloning and expression system. PCR products can be used directly for cloning without ligase treatment, and can be linked to the vector for expression in 5 minutes, and THI0RED0XIN is used. TRX thioredoxin is used as a fusion peptide to express a foreign protein, so that the foreign protein is expressed in a soluble active form.釆 Use PBAD promoter and arabinose as inducer.

PBAD/THI0-T0P0表达引物:  PBAD / THI0-T0P0 expression primers:

5, 引物: GAGAATTCGATGAGCGTTCTGGCCAAATTCAC (SEQ ID Na: 5 ) 3, 引物: GATTACGCAGCGGAAATCCGCCAG (SEQ ID Na : 6) 5. Primer: GAGAATTCGATGAGCGTTCTGGCCAAATTCAC (SEQ ID Na : 5) 3. Primer: GATTACGCAGCGGAAATCCGCCAG (SEQ ID Na: 6)

PCR反应条件:  PCR reaction conditions:

94°C 5分钟, (94°C 1分钟, 59°C 1分钟, 72°C2分钟) 30个循环, 72°C 10 分钟。  94 ° C for 5 minutes, (94 ° C for 1 minute, 59 ° C for 1 minute, 72 ° C for 2 minutes) 30 cycles, 72 ° C for 10 minutes.

PCR反应体系:  PCR reaction system:

以酮古龙酸菌 J(etogulonigeniwn sp. ) WB0104 (CCTCC No. M203094)基因 组 DNA 为模板进行 PCR 反应, 50 μ ΐ 体系中含有终浓度为 ' 1. 5誦 ol/L MgCl2) 0. 2mmol/L dNTPs, 各 0. 2 μ mol/L 的 5' 弓 | 物和 3, 引 物 , lOramol/LTris-HCl, 2uTaqDNA聚合酶。 PCR产物电泳结果如图 1所示, 表明 PCR 产物大小为 1. 3Kb。 图中, b为 PBAD/THI0- T0P0表达引物 PCR产物的电泳结果。 PCR 产物与 PBAD/THI0-T0P0 直接连接 (克隆过程参照 INVIT0RGEN PBAD/T0P0- THI0FUSI0N表达试剂盒) , 然后转化 ΤΟΡΙΟ, 挑单菌落接种到 5mlLB 培养基中 (含 AMP100 g/ml ) 37°C培养过夜, 用 QIAGEN的 MINI质粒提取柱提取 质粒并用酶切验证,找出正确插入 PBAD-rSNDH的质粒后, 确定为阳性克隆。 A PCR reaction was performed using genomic DNA of ketocoronic acid J (etogulonigeniwn sp.) WB0104 (CCTCC No. M203094) as a template. The 50 μΐ system contained a final concentration of '1.5 ol / L MgCl 2) 0.2 mmol / L dNTPs, 0.2 μmol / L 5 'bow | each and 3, primers, lOmolol / LTris-HCl, 2uTaq DNA polymerase. 3Kb。 PCR product electrophoresis results shown in Figure 1, indicating that the PCR product size is 1.3Kb. In the figure, b is the electrophoresis result of the PCR product of the PBAD / THI0-TOP0 expression primer. The PCR product was directly connected to PBAD / THI0-T0P0 (for cloning process, refer to the INVIT0RGEN PBAD / T0P0-THI0FUSI0N expression kit), and then transformed into TOPIO. Single colonies were inoculated into 5ml LB medium (containing AMP100 g / ml) and incubated at 37 ° C overnight Extraction with QIAGEN's MINI plasmid extraction column The plasmid was verified by enzyme digestion, and a plasmid that was correctly inserted into PBAD-rSNDH was found, and it was determined to be a positive clone.

挑阳性克隆单菌落接种到 5mlLB培养基中(含舰 P100 μ g/ml )37 Ό培养过夜, 按 1%接种量接种到 50mlLB培养基中(含 AMP100 μ g/ml )培养至 0D = 0.6-1,加阿 拉伯糖诱导(终浓度 0.02%) ,继续培养 4个小时, 离心收集菌体,进行 SDS- PAGE 检测, 结果如图 3所示, 表明在 57000道尔顿处检测到特异条带, 说明检测到 L- 山梨酮脱氢酶基因的表达产物。 图中, a为 PBAD- rSNDH,分子量标准 (marker) 从大到小分别为 94000, 67000, 43000, 30000; 箭头所指为目的条带。  Pick a single colony of positive clones and inoculate it into 5ml LB medium (including P100 μg / ml) 37 Ό culture overnight, inoculate into 50ml LB medium (containing AMP100 μg / ml) at 1% inoculation volume and culture to 0D = 0.6- 1. Induced with arabinose (final concentration 0.02%), continued to culture for 4 hours, centrifuged to collect bacteria, and tested by SDS-PAGE. The results are shown in Figure 3, indicating that a specific band was detected at 57000 Daltons. This indicates that the expression product of the L-sorbone dehydrogenase gene was detected. In the figure, a is PBAD-rSNDH, and the molecular weight standards (marker) are 94000, 67000, 43000, and 30000 from large to small; the arrows indicate the bands of interest.

3. 毕赤酵母酵母中表达 SNDH  3. Expression of SNDH in Pichia yeast

(1) L-山梨酮脱氢酶基因导入酵母表达载体  (1) Introduction of L-sorbone dehydrogenase gene into yeast expression vector

采用 INVITR0GEN 毕赤酵母 picz α表达系统, 构建在毕赤酵母中表达 rSNDH 的表达载体 piczaA/SND。  The INVITR0GEN Pichia picz α expression system was used to construct the expression vector piczaA / SND expressing rSNDH in Pichia pastoris.

设计引物如下:  Design primers as follows:

5' 引物: CACTCGAGAAAAGA ATGAGCGTTCTGGCCAAATTC (SEQ ID Na: 7) 3' 引物: CACTCGAGTTACGCAGCGGAAATC (SEQ ID NQ: 8) 。 5 'primer: CACTCGAGAAAAGA ATGAGCGTTCTGGCCAAATTC (SEQ ID Na : 7) 3' primer: CACTCGAGTTACGCAGCGGAAATC (SEQ ID NQ: 8).

PCR 反应条件如下:  The PCR reaction conditions are as follows:

94°C 3分钟 然后 30个循环 (94°C1分钟, 62°C1分钟, 72°C2分钟) , 72 °C10分钟。  94 ° C for 3 minutes and then 30 cycles (94 ° C for 1 minute, 62 ° C for 1 minute, 72 ° C for 2 minutes), 72 ° C for 10 minutes.

以酮古龙酸菌 Ketogulonigenium sp. ) WB0104 (CCTCC No. M203094)基因 组 DNA为模板进行 PCR反应, 然后按常规方法将 PCR产物连接 pGEM-T- VECTOR, 转化后挑选白斑菌落, 提质粒, 测序鉴定。 将测序鉴定正确的 pGEM- T-rSNDH和 picz a A质粒 DNA分别用 XHOI处理后, 试剂盒回收约 1200bp和 3.3kb的片段, 用 T4 DNA连接酶连接,连接产物转化转化 DH5 a感受态菌,涂在 LB平板(含 ZE0CIN 25 μ g/ml ) 。 提取质粒, 酶切鉴定。 挑选连接方向与插入大小都正确的重组质粒 picz a A-rSNDH, 用 QIAGEN MIDI质粒提取试剂盒提取质粒, 用于转化毕赤酵母。 Ketogulonigenium sp. WB0104 (CCTCC No. M203094) genomic DNA was used as a template for the PCR reaction, and then the PCR product was ligated to pGEM-T-VECTOR in accordance with conventional methods. After transformation, the white spot colonies were selected, and the plasmid was extracted and sequenced for identification. The correct pGEM-T-rSNDH and picz a A plasmid DNA identified by sequencing were treated with XHOI, respectively. The kit recovered approximately 1200bp and 3.3kb fragments, and ligated with T 4 DNA ligase. The ligated products were transformed into DH5 a competent bacteria. Coated on LB plate (containing ZE0CIN 25 μg / ml). The plasmid was extracted and identified by enzyme digestion. Select the recombinant plasmid picz a A-rSNDH with the correct ligation direction and insertion size, and use the QIAGEN MIDI plasmid extraction kit to extract the plasmid for transformation into Pichia pastoris.

(2) 重组质粒的线性化  (2) Linearization of the recombinant plasmid

将重组质粒 20 μ g picz a A-rSNDH用 Sac /单酶切后, 用水扩大至 300μ1体 系, 等体积的酚:氯仿:异戊醇 (25:24:1)抽提 1次, 上清加 1/10体积 3MNaAc 和 2.5倍体积无水乙醇沉淀 DNA, 70%乙醇洗涤后, 真空抽干, 溶于 20μ1 ΤΕ。  20 μg picz a A-rSNDH was digested with Sac / single enzyme, and then expanded to 300 μ1 with water. An equal volume of phenol: chloroform: isoamyl alcohol (25: 24: 1) was extracted once, and the supernatant was added. DNA was precipitated by 1/10 volume of 3M NaAc and 2.5 times volume of absolute ethanol, washed with 70% ethanol, dried under vacuum, and dissolved in 20 μ1 TE.

(3) 感受态酵母宿主细胞的制备  (3) Preparation of competent yeast host cells

接种毕赤酵母表达宿主菌 X- 33于 5ml YPD培养基中, 3CTC振摇过夜, 次日 转到 500ml新鲜 YPD培养基中, 30°C振摇培养至 A6。。™«1.3- 1· 5, 4°C 5000rpm离 心 5min, 弃上清, 分别以 500ml、 250ml冰冷灭菌水及 20ml冰冷 1M山梨醇重悬 洗涤菌体, 将细胞重悬于 lml冰冷 1M山梨醇中, 制备成感受态。 Inoculated Pichia expression hosts X- 33 in 5ml YPD medium, 3CTC shaken overnight, the next day to 500ml fresh YPD medium, 30 ° C with shaking to A 6. . ™ «1.3- 1 · 5, 4 ° C 5000rpm The heart was discarded for 5 minutes, and the supernatant was discarded, and the cells were washed and resuspended in 500 ml, 250 ml of ice-cold sterilized water and 20 ml of ice-cold 1M sorbitol, and the cells were resuspended in 1 ml of ice-cold 1M sorbitol to prepare competent cells.

(4)电转化  (4) Electric conversion

将 ΙΟΟμΙ感受态细胞与 5- 10μ§线性化的重组质粒混合,转入 0. 2cm电转杯, 冰浴 5min, 于 Bio- Rad Gene Pulser电转仪 1500V, 25μΨ, 200 Ω条件下电转化, 立即加入 lml冰浴 1M山梨醇, 取 ΙΟΟμΙ涂布于 YPDS含 ZEOCIN(Invitrogen) 100 μ g/ml选择平板上, 30°C孵育 2- 3d,出现转化子。 Mix 100 μl competent cells with 5- 10 μ § linearized recombinant plasmid, transfer to a 0.2 cm electric rotor, and ice-bath for 5 min. In a Bio-Rad Gene Pulser electro-rotator at 1500 V, 25 μΨ, 200 Ω, transform immediately and add immediately. 1ml sorbitol in 1ml ice bath was taken and spread on 100 μg of YPDS containing ZEOCIN (Invitrogen) 100 μg / ml selection plate and incubated at 30 ° C for 2 to 3 days. Transformants appeared.

(5)阳性克隆的直接 PCR检测  (5) Direct PCR detection of positive clones

接种转化子单菌落于 ΙΟμΙ无菌水中, 加入 5μ1 溶细胞酶 (51]/μ1), 30°C振 摇 lOmin, 置于液氮气相 lmin, 室温下解冻后直接用作模板, 用一对检测引物 a- Factor禾口 3, A0X1 (Invitrigen easy select Pichia Expression Kit Manual) 进行 PCR检测, 结果检测到 L-山梨酮脱氢酶基因。  A single colony of the transformant was inoculated in 10 μl of sterile water, 5 μ1 of lysozyme (51) / μ1) was added, shaken at 30 ° C for 10 min, and placed in a liquid nitrogen phase for 1 min. After thawing at room temperature, it was directly used as a template. Primer a- Factor Hekou 3, A0X1 (Invitrigen easy select Pichia Expression Kit Manual) was used for PCR detection, and the L-sorbone dehydrogenase gene was detected.

(6 ) 表达实验  (6) Expression experiment

接种转化子单菌落于 50mlBMGY培养基于 30°C培养至 A6。。nm«4. 0时,每日补甲 醇, 氨水, 诱导表达 6d, 样品离心收集上清, SDS- PAGE分析, 结果如图 4所示, 表明在 45000道尔顿处检测到特异条带,说明检测到 L-山梨酮脱氢酶基因的表达 产 物 。 图 中 , 箭 头 所 指 为 rSNDH , 分 子 量 标 准 依 次 为 94000, 67000, 43000, 30000, 20100。 Transformant single colonies were inoculated in 50 ml BMGY medium and cultured at 30 ° C to A 6 . . When nm «4.0, daily supplementation with methanol, ammonia, and induced expression for 6 days, the samples were centrifuged to collect the supernatant, and analyzed by SDS-PAGE. The results are shown in Figure 4, indicating that a specific band was detected at 45,000 Daltons. An expression product of the L-sorbone dehydrogenase gene was detected. In the figure, the arrow points to rSNDH, and the molecular weight standards are 94000, 67000, 43000, 30000, and 20100.

实施例 3、 L-山梨酮脱氢酶基因功能验证  Example 3. Functional verification of L-sorbone dehydrogenase gene

1、 以 NAD为辅酶, 酶活性测定  1. Using NAD as coenzyme, determination of enzyme activity

参照文献(Agri. Biol. Chem. 54(5) 121卜 1218, 1990)和 SugiSANA等(Agric, Biol, Chem, 55, 363-370, 1991 ) , 以 L -山梨酮为底物、 AD 为电子受体, 测 定波长 340nm处的光吸收值。 所建立的以 L-山梨酮为底物, 以 NAD 为辅酶的酶 活活性测定方法: 基本反应液由 L-山梨酮 2. Omg, NAD 0. ½g, PB 50mM, pH7. 0 组成, 在 25°C水浴条件下, 分别加入实施例 2中三种表达系统所表达的 L-山梨 酮脱氢酶 (rSNDH) 粗酶 0. lmg/ml各 10ul, 总体积 820ul, 阳性克隆酵母 X- 33 选上清液, 阳性克隆大肠杆菌 BL21 (DE3)和 T0P10菌体破壁去上清, 测定 340nm 处光吸收的变化率, 测定结果显示各种形式表达的 rSNDH均有活性, 其中在阳性 克隆大肠杆菌 T0P10融合表达的 rSNDH的活性如图 5所示, 表明融合 rSNDH有 酶活活性,酶活力为 0. 1217u/mg o远高于文献报导的粗酶活性(48. 5mu/mg)。(酶 活力单位定义为每分钟催化还原 luMol NAD所需的酶量。 经测定表明该酶将 L - 山梨酮转化为 2 -KGA的 PH范围为 5. 0-9. 0, 其中最适作用 1¾为 7. 5, 如图 7所 示。 References (Agri. Biol. Chem. 54 (5) 121, 1218, 1990) and SugiSANA et al. (Agric, Biol, Chem, 55, 363-370, 1991), with L-sorbone as the substrate and AD as the electron Acceptor, and measured the light absorption value at a wavelength of 340 nm. The established method for determining the enzymatic activity of L-sorbone as a substrate and NAD as a coenzyme: The basic reaction solution was composed of L-sorbone 2.0 Omg, NAD 0. ½g, PB 50mM, pH7.0, at 25 Under the condition of a water bath of ° C, L-sorbitan dehydrogenase (rSNDH) crude enzyme expressed by the three expression systems in Example 2 was added separately 0.1 μg / ml 10 ul, total volume 820 ul, and positive clone yeast X- 33 was selected. Supernatant, positive clones E. coli BL21 (DE3) and TOP10 bacterial cells were broken to remove the supernatant, and the change rate of light absorption at 340 nm was measured. The results showed that rSNDH expressed in various forms was active. The activity of rSNDH expressed by TOP10 fusion is shown in Figure 5, which indicates that the fusion rSNDH has enzymatic activity, and the enzymatic activity is 0.117 u / mg o, which is much higher than the crude enzyme activity reported in the literature (48.5 mu / mg). (The unit of enzyme activity is defined as the amount of enzyme required to catalyze the reduction of luMol NAD per minute. Measurements have shown that this enzyme converts L- The pH range for the conversion of sorbone to 2 -KGA is 5.0-9. 0, of which the optimal action 1¾ is 7.5, as shown in FIG. 7.

2. rSNDH对 L-山梨酮的体外转化  2. rSNDH in vitro transformation of L-sorbone

通过 Chelating- SFF层析对阳性克隆大肠杆菌 T0P10融合表达的 rSNDH进行 纯化, 其中层析柱: 1. 6 X 10cm, 亲和离子: Ni2+, 层析条件: 50 mM PB 缓冲液, pH7. 0,咪唑(Imidazole )梯度。纯化结果如图 6所示,箭头所指为纯化的 rSNDH, 分子量约为 57000, 分子量标准依次为 94000, 67000, 43000, 30000, 20100。 The rSNDH expressed by the fusion of the positive clone E. coli TOP10 was purified by Chelating-SFF chromatography, wherein the chromatography column: 1. 6 X 10cm, affinity ion: Ni 2+ , chromatography conditions: 50 mM PB buffer, pH 7. 0, Imidazole gradient. The purification result is shown in Fig. 6. The arrow indicates the purified rSNDH, the molecular weight is about 57000, and the molecular weight standards are 94000, 67000, 43000, 30000, 20100 in that order.

按常规方法进行了 rSNDH对 L-山梨酮的体外转化试验, 反应体系: 缓冲 液: 50mM PB, pH8. 0, L-山梨酮: 5mg/ml, rSNDH酶: 0. 08mg/ral, NAD : 0. 5mg/ml。 37°C反应 5小时, 产物 2-KGA以 HPLC方法定量测定, 结果如图 8、 9、 10和 11 所示, 表明 rSNDH在体外将 L-山梨酮转化为 2-KGA,辅酶 NAD的存在有效地提高 2 - KGA的转化率。 图中 2- KGA 的标准品浓度为: 2mg/ml ; L-山梨酮的标准品浓 度为: 2mg/ml ; 在无辅酶存在的条件下, 2- KGA 的生成浓度为: 0. 86 mg/ml ; 在 有辅酶存在的条件下, 2- KGA 的生成浓度为: 1. 42 mg/ml。 其中对无 NAD参与反 应的转化试验用 LS- MS验证 2 -KGA的产生 (电喷雾电离源: ESI, 电喷雾电压: 3. 0KV, 电喷雾接口干燥气: N2, 流速: 250L/hr,脱溶剂温度: 190 °C, 碰撞诱导 解离电压: 30V, 离子源温度: 120Ό ) , 结果如图 12和 13所示, 证明有 2 -KGA 的特征吸收。 The in vitro conversion test of L-sorbitan by rSNDH was performed according to the conventional method. The reaction system: buffer: 50 mM PB, pH 8. 0, L-sorbone: 5 mg / ml, rSNDH enzyme: 0.08 mg / ral, NAD: 0 5mg / ml. The reaction was performed at 37 ° C for 5 hours, and the product 2-KGA was quantitatively determined by HPLC. The results are shown in Figures 8, 9, 10, and 11, indicating that rSNDH converts L-sorbone to 2-KGA in vitro, and the presence of coenzyme NAD is effective. Increase the conversion rate of 2-KGA. In the figure, the standard concentration of 2-KGA is: 2mg / ml; the standard concentration of L-sorbone is: 2m g / ml; in the absence of coenzyme, the concentration of 2-KGA is: 0.86 m g / ml; In the presence of coenzyme, the production concentration of 2- KGA is: 1. 42 mg / ml. Transformation test in which no part in the reaction NAD verification LS- MS 2 -KGA production (electrospray ionization: ESI, electrospray voltage: 3. 0KV, electrospray interfaces drying gas: N 2, flow rate: 250L / hr, Desolvation temperature: 190 ° C, collision-induced dissociation voltage: 30V, ion source temperature: 120Ό), and the results are shown in Figs. 12 and 13, which demonstrate the characteristic 2-KGA absorption.

实施例 4、 表达 rSNDH 的宿主与酮古龙酸菌 WB0104共培养  Example 4.Co-cultivation of rSNDH-expressing host with ketocolic acid WB0104

将培养好的酮古龙酸菌薦0104种液及含有或无 PBAD-rSNDH质粒的 E. coli T0P10混合 (10 : 1 ) 共 3ml (含 L -山梨糖 2. 0%)接种到 20ml发酵培养基中, 发酵 瓶培养基: L-山梨糖 8. 0%, 酵母膏 0. 2%, 玉米浆 2. 0%, 尿素 1. 2%, K¾P040. 1%, MgS04. 7Η200. 01%,轻质碳酸钙 0. 5%。 在 29°C, 200rpm条件'下培养, 在 24h测定古 龙酸含量、 40h左右取样测发酵液体积、 测定 L-山梨糖 (蒽酮法) 和 2-酮基- L- 古龙酸含量 (HPLC法) , 根据 L-山梨糖含量确定发酵终点取样时间, 并计算最 终转化率。 结果如表 1所示, 表明 r^SMW的表达显著提高 2- KGA的转化率。 0104 kinds of cultured ketocoronic acid bacteria and E. coli T0P10 with or without PBAD-rSNDH plasmid were mixed (10: 1) for a total of 3ml (containing L-sorbose 2.0%) inoculated into 20ml fermentation medium Medium of fermentation bottle: L-sorbose 8.0%, yeast extract 0.2%, corn pulp 2.0%, urea 1.2%, K¾P0 4 0.1%, MgS0 4.2 00. 5%。 01%, light calcium carbonate 0.5%. Incubate at 29 ° C and 200 rpm, measure the colic acid content at 24 h, sample the fermentation broth volume at about 40 h, measure the L-sorbose (anthrone method) and 2-keto-L-gulonic acid content (HPLC method ), Determine the fermentation end sampling time according to the L-sorbose content, and calculate the final conversion rate. The results are shown in Table 1, indicating that the expression of r ^ SMW significantly increased the conversion rate of 2-KGA.

古龙酸量 (g/ml)*发酵体积 (ml)*0.928 Amount of colic acid (g / ml) * Fermentation volume (ml) * 0.928

转化率 (%) = *100%  Conversion rate (%) = * 100%

L-山梨糖量 (g) 表 1 酮古龙酸菌 WB0104和 PBAD-rSNDH对 L-山梨糖的转化 L-sorbose (g) Table 1 Conversion of L-sorbose by ketocolic acid WB0104 and PBAD-rSNDH

Figure imgf000012_0001
Figure imgf000012_0001

注: 阿拉伯糖的终浓度为 0.02% 工业应用性 本发明通过对酮古龙酸菌 Ketogulonigenium sp. ) WB0104 CCTCC Note: The final concentration of arabinose is 0.02%. Industrial applicability The present invention is based on Ketogulonigenium sp. WB0104 CCTCC.

NO. M203094的全基因组序列测定, 经基因注释, 预测出与 2-酮基- L-古龙酸合成 有关的关键酶基因一 L-山梨酮脱氢酶基因 irSNDH) 。 用分子生物学手段将该基 因表达于不同的载体及宿主中所产生的蛋白(酶)均能在体外有效地将 L-山梨酮 转化为 2-酮基 -L-古龙酸 (2- KGA) , 不论任何形式表达的 SNDH (包含体, 分泌 蛋白, 融合蛋白) 均在体外具有 SNDH酶活性, 同时, 携有本发明的 rSNDH编码 基因的 £ coli工程菌与 2- KGA转化菌共培养时,本发明的 rSNDH显著提高 2- KGA 的转化率。可利用本发明的 L-山梨酮脱氢酶基因对现有的 2- KGA产生菌进行改造、 定向育种, 提高 2-KGA的产量,如将本发明的 L-山梨酮脱氢酶基因或其突变体或 片段插入现有的 2-KGA产生菌基因组中, 以增强 L-山梨酮脱氢酶的活性,或用分 子生物学手段表达本发明的 L-山梨酮脱氢酶基因,利用固定化酶法或固定化细胞 法在体外合成 2-KGA, 或合成本发明的 L-山梨酮脱氢酶基因对应的蛋白质用于 2-KGA的生产, 降低 2-KGA的生产成本、 提高 2- KGA的转化率、 减少对环境的污 染、 减少生产过程对能源的需求、 提高产品的质量, 本发明具有重要的工业应用 前景。 The genome-wide sequence of NO. M203094 was determined by gene annotation to predict the key enzyme gene related to 2-keto-L-gulonic acid synthesis-the L-sorbone dehydrogenase gene (irSNDH). The protein (enzyme) produced by expressing this gene in different vectors and hosts by molecular biology methods can effectively convert L-sorbone to 2-keto-L-gulonic acid (2-KGA) in vitro SNDH (including bodies, secreted proteins, and fusion proteins) expressed in any form has SNDH enzyme activity in vitro, and at the same time, when the engineered coli bacteria carrying the rSNDH-encoding gene of the present invention is co-cultured with 2-KGA transforming bacteria, The rSNDH of the present invention significantly improves the conversion rate of 2-KGA. The L-sorbone dehydrogenase gene of the present invention can be used to modify existing 2-KGA-producing bacteria and conduct targeted breeding to increase the yield of 2-KGA. For example, the L-sorbone dehydrogenase gene of the present invention or the The mutant or fragment is inserted into the existing 2-KGA-producing bacteria genome to enhance the activity of L-sorbone dehydrogenase, or to express the L-sorbone dehydrogenase gene of the present invention by molecular biology means, and the immobilization Enzyme method or immobilized cell method to synthesize 2-KGA in vitro, or synthesize the protein corresponding to the L-sorbone dehydrogenase gene of the present invention for the production of 2-KGA, reduce the production cost of 2-KGA, and increase the 2-KGA The present invention has important industrial application prospects by reducing the environmental pollution, reducing the demand for energy during the production process, and improving the quality of products.

Claims

权利要求 Rights request 1、 一种 L-山梨酮脱氢酶, 是具有序列表中 SEQ ID No : 2氨基酸残基序列的 蛋白质或与序列表中 SEQ ID No : 2的氨基酸残基序列具有至少 80%同源性且具有 与 SEQ ID No : 2相同活性的由 SEQ ID Na: 2衍生的蛋白质。 A L- sorbosone dehydrogenase, is having the sequence of SEQ ID No: 2 in the Sequence Listing or a protein amino acid residue sequence in SEQ ID No: 2 amino acid residue sequence having at least 80% homology And a protein derived from SEQ ID Na: 2 having the same activity as SEQ ID No : 2. 2、 根据权利要求 1所述的 L-山梨酮脱氢酶, 其特征在于: 所述 L-山梨酮脱 氢酶是具有序列表中 SEQ ID Na : 2氨基酸序列的蛋白质。  2. The L-sorbone dehydrogenase according to claim 1, wherein the L-sorbone dehydrogenase is a protein having the amino acid sequence of SEQ ID Na: 2 in the sequence listing. 3、 根据权利要求 1所述的 L-山梨酮脱氢酶, 其特征在于: 所述与序列表中 SEQ ID Na : 2的氨基酸残基序列具有至少 80%同源性且具有与 SEQ ID Ns : 2相 同活性的由 SEQ ID No : 2衍生的蛋白质为与 SEQ ID Na : 2具有至少 90%同源性 且具有与 SEQ ID No .. 2相同活性的由 SEQ ID Ne : 2衍生的蛋白质。 3. The L-sorbone dehydrogenase according to claim 1, characterized in that: said sequence has at least 80% homology with the amino acid residue sequence of SEQ ID Na: 2 in the sequence listing and has SEQ ID Ns : 2 The protein derived from SEQ ID No : 2 with the same activity is a protein derived from SEQ ID Ne: 2 that has at least 90% homology with SEQ ID Na : 2 and has the same activity as SEQ ID No .. 2. 4、 根据权利要求 1所述的 L-山梨酮脱氢酶, 其特征在于: 所述 L-山梨酮脱 氢酶是将与序列表中 SEQ ID Na : 1具有至少 80%同源性的序列在宿主菌大肠杆菌 或毕赤酵母中表达得到的蛋白质。  4. The L-sorbone dehydrogenase according to claim 1, wherein the L-sorbone dehydrogenase is a sequence that will have at least 80% homology with SEQ ID Na: 1 in the sequence listing. The resulting protein is expressed in host bacteria E. coli or Pichia. 5、 一种 L-山梨酮脱氢酶的编码基因, 是下列核苷酸序列之一- 5. A gene encoding L-sorbone dehydrogenase, which is one of the following nucleotide sequences − 1 ) 序列表中的 SEQ ID Na : 1; 1) SEQ ID Na in the sequence list: 1; 2) 编码序列表中 SEQ ID No : 2蛋白质序列的多核苷酸; 2) a polynucleotide encoding the protein sequence of SEQ ID No : 2 in the sequence listing; 3) 与序列表中 SEQ ID No : 1限定的 DNA序列具有 80%以上同源性, 且编码 相同功能蛋白质的 DNA序列。 3) A DNA sequence with more than 80% homology to the DNA sequence defined by SEQ ID No : 1 in the Sequence Listing, and encoding the same functional protein. 6、 含有权利要求 5所述基因的表达载体和细胞系。  6. An expression vector and a cell line containing the gene according to claim 5. 7、 根据权利要求 6所述的表达载体和细胞系, 其特征在于: 所述细胞系为 含有 L-山梨酮脱氢酶编码基因的大肠杆菌或毕赤酵母。  7. The expression vector and cell line according to claim 6, wherein the cell line is E. coli or Pichia yeast containing a gene encoding L-sorbone dehydrogenase. 8、 根据权利要求 7所述的表达载体和细胞系, 其特征在于: 所述细胞系为 固定化细胞。  8. The expression vector and cell line according to claim 7, wherein the cell line is an immobilized cell. 9、一种表达 L-山梨酮脱氢酶的方法,是将以酮古龙酸菌 iKetogulonigeniim sp. ) WB0104 CCTCC No. M203094基因组 DNA为模板扩增得到的 L-山梨酮脱氢酶 的编码基因导入表达宿主菌, 得到阳性克隆, 培养阳性克隆, 表达 L-山梨酮脱氢 酶。  9. A method for expressing L-sorbone dehydrogenase, which comprises introducing a gene encoding L-sorbone dehydrogenase amplified by genomic DNA of ketocoronic acid bacteria iKetogulonigeniim sp. WB0104 CCTCC No. M203094 as a template The host bacteria were expressed to obtain positive clones, and the positive clones were cultured to express L-sorbone dehydrogenase. 10、 根据权利要求 9所述的方法, 其特征在于: 所述以酮古龙酸菌  10. The method according to claim 9, characterized in that: the ketocolic acid bacteria {Ketogulonigenium sp. ) WB0104 CCTCC No. M203094基因组 DNA为模板扩增 (Ketogulonigenium sp.) WB0104 CCTCC No. M203094 Amplification of genomic DNA as a template L-山梨酮脱氢酶基因的一对引物为序列表中 SEQ ID No : .3和 SEQ ID Na : 4、 SEQ ID No : 5和 SEQ ID Na: 6或 SEQ ID Na: 7和 SEQ ID Ns: 8。 The pair of primers of the L-sorbone dehydrogenase gene are SEQ ID No : .3 and SEQ ID Na : 4, SEQ ID No : 5 and SEQ ID Na : 6 or SEQ ID Na : 7 and SEQ ID Ns: 8. 11、根据权利要求 9所述的方法, 其特征在于: 所述阳性克隆为含有 L-山梨 酮脱氢酶基因的大肠杆菌 DH5 ct、 大肠杆菌 BL21 (DE3) 、 大肠杆菌 T0P10或毕 赤酵母 X - 33。  11. The method according to claim 9, characterized in that: the positive clones are E. coli DH5 ct, E. coli BL21 (DE3), E.coli TOP10, or Pichia X which contain an L-sorbone dehydrogenase gene. -33. 12、权利要求 1至 4任一所述的 L-山梨酮脱氢酶在将 L-山梨酮转化为 2- KGA 过程中的应用。  12. Use of the L-sorbone dehydrogenase according to any one of claims 1 to 4 in the process of converting L-sorbone to 2-KGA. 13、 权利要求 5所述的 L-山梨酮脱氢酶的编码基因在将 L-山梨酮转化为 2-KGA过程中的应用。  13. Use of a gene encoding L-sorbone dehydrogenase according to claim 5 in the process of converting L-sorbone to 2-KGA. 14、权利要求 6至 8任一所述的含有 L-山梨酮脱氢酶的编码基因的表达载体 和细胞系在将 L-山梨酮转化为 2- KGA过程中的应用。  14. Use of an expression vector and a cell line containing a gene encoding an L-sorbone dehydrogenase according to any one of claims 6 to 8 in the process of converting L-sorbone to 2-KGA. 15、 权利要求 5所述的基因在增强 L-山梨酮脱氢酶活性中的应用。  15. Use of the gene according to claim 5 in enhancing L-sorbone dehydrogenase activity.
PCT/CN2004/001356 2003-11-28 2004-11-26 A L-sorbosone dehydrogenase as well as the encoding gene and the use thereof Ceased WO2005052160A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNB2003101168317A CN100395332C (en) 2003-11-28 2003-11-28 A kind of L-sorbosone dehydrogenase and its coding gene and application
CN200310116831.7 2003-11-28

Publications (1)

Publication Number Publication Date
WO2005052160A1 true WO2005052160A1 (en) 2005-06-09

Family

ID=34624439

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2004/001356 Ceased WO2005052160A1 (en) 2003-11-28 2004-11-26 A L-sorbosone dehydrogenase as well as the encoding gene and the use thereof

Country Status (2)

Country Link
CN (1) CN100395332C (en)
WO (1) WO2005052160A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012174978A1 (en) * 2011-06-20 2012-12-27 天津大学 Strain improvement and process optimization in two-step mixed fermentation for production of vitamin c
CN102676552A (en) * 2012-05-25 2012-09-19 江南大学 Novel L-sorbosone dehydrogenase gene and application thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352599A (en) * 1988-01-14 1994-10-04 Hoffmann-La Roche Inc. Co-enzyme-independent L-sorbosone dehydrogenase of gluconobacter oxydans: isolation, characterization, and cloning and autologus expression of the gene
US6197562B1 (en) * 1993-03-08 2001-03-06 Fujisawa Pharmaceutical Co., Ltd. L-sorbose dehydrogenase and novel L-sorbosone dehydrogenase obtained from gluconobacter oxydans T-100
CN1332249A (en) * 1994-02-25 2002-01-23 藤泽药品工业株式会社 Process for production of 2-ketone-L-gulonic acid
WO2003008588A2 (en) * 2001-07-13 2003-01-30 Basf Aktiengesellschaft Method for producing 2-keto-l-gulonic acid and vitamin c while using l-sorbose dehydrogenase and l-sorbosone dehydrogenase
US20030087440A1 (en) * 2000-04-05 2003-05-08 Archer-Daniels-Midland Company Ketogulonigenium endogenous plasmids

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352599A (en) * 1988-01-14 1994-10-04 Hoffmann-La Roche Inc. Co-enzyme-independent L-sorbosone dehydrogenase of gluconobacter oxydans: isolation, characterization, and cloning and autologus expression of the gene
US6197562B1 (en) * 1993-03-08 2001-03-06 Fujisawa Pharmaceutical Co., Ltd. L-sorbose dehydrogenase and novel L-sorbosone dehydrogenase obtained from gluconobacter oxydans T-100
CN1332249A (en) * 1994-02-25 2002-01-23 藤泽药品工业株式会社 Process for production of 2-ketone-L-gulonic acid
US20030087440A1 (en) * 2000-04-05 2003-05-08 Archer-Daniels-Midland Company Ketogulonigenium endogenous plasmids
WO2003008588A2 (en) * 2001-07-13 2003-01-30 Basf Aktiengesellschaft Method for producing 2-keto-l-gulonic acid and vitamin c while using l-sorbose dehydrogenase and l-sorbosone dehydrogenase

Also Published As

Publication number Publication date
CN100395332C (en) 2008-06-18
CN1621518A (en) 2005-06-01

Similar Documents

Publication Publication Date Title
CN109666658B (en) Nicotinamide phosphoribosyltransferase, encoding gene, recombinant vector and application for preparing NMN
CN108570425B (en) A kind of Bradyrhizobium monooxygenase and its application in the preparation of chiral sulfoxide
WO2002036779A1 (en) Novel glucose dehydrogenase and process for producing the dehydrogenase
CN111019878B (en) Recombinant Escherichia coli with improved L-threonine yield, construction method and application thereof
WO2010053161A1 (en) Modified flavin-adenine-dinucleotide-dependent glucose dehydrogenase
CN117448292A (en) 17 beta-hydroxysteroid dehydrogenase mutant and application thereof in preparation of steroid hormone
CN111485008A (en) Biological preparation method of cis-5-hydroxy-L-hexahydropicolinic acid
CN110283800B (en) Glucose oxidation enzyme mutant, double enzyme coexpression vectors and its application
CN114480236B (en) Construction method of one-step bacillus gluconate chassis cell bank for producing 2-KLG
CN112680484B (en) A method for producing 3,4-dihydroxybutyric acid using a double bacteria co-cultivation system
CN112941062B (en) Nitrile hydratase lysine mutant HBA-K2H1, coding gene and application
CN107988092B (en) Stress-tolerant Arthrobacter simplex mutant strains and engineered bacteria
WO2005052160A1 (en) A L-sorbosone dehydrogenase as well as the encoding gene and the use thereof
Jiang et al. Molecular cloning and functional characterization of a novel decarboxylase from uncultured microorganisms
CN113278599A (en) Saccharomyces cerevisiae carbonyl reductase and application thereof in preparation of optically active alkyl lactone
CN113106082A (en) Alanine racemase from animal manure metagenome as well as preparation and application thereof
CN104560832B (en) A kind of Lactobacillus brevis, aldolase and its gene and the method for preparing statin intermediate
CN117802058A (en) Formate dehydrogenase mutant and preparation method and application thereof, and preparation method of NADH
CN101085987B (en) L-sorbinose dehydrogenase and its coding gene and uses
CN111254170B (en) Method for preparing (S) -1,2,3, 4-tetrahydroisoquinoline-3-formic acid by multienzyme coupling
JP6461793B2 (en) Method for producing flavin adenine dinucleotide-binding glucose dehydrogenase from Mucor
CN114540397A (en) Method for enhancing expression of regulatory protein to improve fermentation level of glutamine transaminase
CN110467655B (en) A protein and its application
CN1291031C (en) Method for preparing recombined thymosin alpha 1
Soto et al. The disruption of a gene encoding a putative arylesterase impairs pyruvate dehydrogenase complex activity and nitrogen fixation in Sinorhizobium meliloti

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase